The CADTH Drug Portfolio Information Sessions are an opportunity to receive an update on our drug portfolio, including CADTH’s Common Drug Review (CDR), pan-Canadian Oncology Drug Review (pCODR), and Therapeutic Reviews. Updates on other relevant CADTH initiatives will also be provided.
The sessions will be presented in English and can be attended in person or by webinar. Registration closes Thursday, September 28, 2017.
Please click the appropriate link below to register for a session:
Patient Groups, Policy-Makers, and Health Care Professionals
9:30 a.m. to 12:00 p.m. EST
Pharmaceutical Industry and Consultants
1:30 p.m. to 4:00 p.m. EST
Questions may be sent by email to Events@cadth.ca